Peter Scott Chin, insider filing for DNLI
Peter Scott Chin, reporting
DNLI
Denali Therapeutics Inc. SEC filings
Every EDGAR filing for Denali Therapeutics Inc. (DNLI), newest first, with AI summaries and stories.
- Ticker
- DNLI
- CIK
- 1714899
- Latest filing
- Sep 9
Next: earnings expected ~Nov 6 · 10-Q expected ~Nov 6 (deadline Nov 9)
Filings
4Denali Therapeutics Inc.DNLILIVE 144Denali Therapeutics Inc.DNLILIVE Peter Scott Chin, planned sale of DNLI shares
Peter Scott Chin, reporting
4Denali Therapeutics Inc.DNLILIVE Nancy Thornberry, insider filing for DNLI
Nancy Thornberry, reporting
4Denali Therapeutics Inc.DNLILIVE Alexander O. Schuth, insider filing for DNLI
Alexander O. Schuth, reporting
144Denali Therapeutics Inc.DNLILIVE Nancy Thornberry, planned sale of DNLI shares
Nancy Thornberry, reporting
144Denali Therapeutics Inc.DNLILIVE Alexander O. Schuth, planned sale of DNLI shares
Alexander O. Schuth, reporting
4Denali Therapeutics Inc.DNLILIVE Ryan J. Watts, insider filing for DNLI
Ryan J. Watts, reporting
4Denali Therapeutics Inc.DNLILIVE Alexander O. Schuth, insider filing for DNLI
Alexander O. Schuth, reporting
144Denali Therapeutics Inc.DNLILIVE Alexander O. Schuth, planned sale of DNLI shares
Alexander O. Schuth, reporting
10-QDenali Therapeutics Inc.DNLILIVE 8-KDenali Therapeutics Inc.DNLILIVE SCHEDULE 13G/ADenali Therapeutics Inc.DNLILIVE Ownership stake disclosure by BAILLIE GIFFORD & CO (amended)
BAILLIE GIFFORD & CO, filed by
8-KDenali Therapeutics Inc.DNLILIVE SCHEDULE 13G/ADenali Therapeutics Inc.DNLILIVE Ownership stake disclosure by T. Rowe Price Investment Management, Inc. (amended)
T. Rowe Price Investment Management, Inc., filed by
8-KDenali Therapeutics Inc.DNLILIVE 4Denali Therapeutics Inc.DNLILIVE 8 insider filings
Jay T Flatley, insider filing for DNLI
Show all 8
- 4Insider filing for DNLI
- 4Insider filing for DNLI
- 4Insider filing for DNLI
- 4Insider filing for DNLI
- 4Insider filing for DNLI
- 4Insider filing for DNLI
- 4Insider filing for DNLI
- 4Insider filing for DNLI
Jay T Flatley, reporting
SCHEDULE 13GDenali Therapeutics Inc.DNLILIVE Ownership stake disclosure by T. Rowe Price Investment Management, Inc.
T. Rowe Price Investment Management, Inc., filed by
10-QDenali Therapeutics Inc.DNLILIVE 8-KDenali Therapeutics Inc.DNLILIVE SCHEDULE 13G/ADenali Therapeutics Inc.DNLILIVE Ownership stake disclosure by FMR LLC (amended)
FMR LLC, filed by
3/ADenali Therapeutics Inc.DNLILIVE Peter Scott Chin, new insider at DNLI (amended)
Peter Scott Chin, reporting
DEFA14ADenali Therapeutics Inc.DNLILIVE ARSDenali Therapeutics Inc.DNLILIVE DEF 14ADenali Therapeutics Inc.DNLILIVE 3Denali Therapeutics Inc.DNLILIVE Peter Scott Chin, new insider at DNLI
Peter Scott Chin, reporting
8-KDenali Therapeutics Inc.DNLILIVE 8-KDenali Therapeutics Inc.DNLILIVE SCHEDULE 13G/ADenali Therapeutics Inc.DNLILIVE Ownership stake disclosure by VANGUARD GROUP INC (amended)
VANGUARD GROUP INC, filed by
8-KDenali Therapeutics Inc.DNLILIVE 10-KDenali Therapeutics Inc.DNLILIVE S-8Denali Therapeutics Inc.DNLILIVE 8-KDenali Therapeutics Inc.DNLILIVE 144Denali Therapeutics Inc.DNLILIVE Carole Ho, planned sale of DNLI shares
Carole Ho, reporting
144Denali Therapeutics Inc.DNLILIVE Carole Ho, planned sale of DNLI shares
Carole Ho, reporting
144Denali Therapeutics Inc.DNLILIVE Carole Ho, planned sale of DNLI shares
Carole Ho, reporting
4Denali Therapeutics Inc.DNLILIVE 2 insider filings
Ryan J. Watts, insider filing for DNLI
Show all 2
- 4Insider filing for DNLI
- 4Insider filing for DNLI
Ryan J. Watts, reporting
144Denali Therapeutics Inc.DNLILIVE 3 Form 144 notices
Carole Ho, planned sale of DNLI shares
Show all 3
- 144Planned insider sale of DNLI shares
- 144Planned insider sale of DNLI shares
- 144Planned insider sale of DNLI shares
Carole Ho, reporting
8-KDenali Therapeutics Inc.DNLILIVE 4Denali Therapeutics Inc.DNLILIVE 2 insider filings
Alexander O. Schuth, insider filing for DNLI
Show all 2
- 4Insider filing for DNLI
- 4Insider filing for DNLI
Alexander O. Schuth, reporting